Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Omega Diagnostics Group PLC
  6. Summary
    ODX   GB00B1VCP282

OMEGA DIAGNOSTICS GROUP PLC

(ODX)
  Report
Delayed London Stock Exchange  -  06:10 2022-12-05 am EST
3.270 GBX   -3.82%
11/25IN BRIEF: Omega Diagnostics receives CD4 deferred consideration
AN
11/25Omega Diagnostics Receives $5 Million Deferred Consideration From CD4 Sale
MT
11/24Transcript : Omega Diagnostics Group PLC, Q2 2023 Earnings Call, Nov 24, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/29/2022 11/30/2022 12/01/2022 12/02/2022 12/05/2022 Date
3.6(c) 3.4(c) 3.35(c) 3.4(c) 3.27 Last
802 908 1 373 401 321 303 258 040 104 713 Volume
+1.41% -5.56% -1.47% +1.49% -3.82% Change
More quotes
Estimated financial data (e)
Sales 2023 10,0 M 12,2 M 12,2 M
Net income 2023 -1,00 M -1,22 M -1,22 M
Net cash position 2023 6,20 M 7,59 M 7,59 M
P/E ratio 2023 -6,80x
Yield 2023 -
Sales 2024 13,0 M 15,9 M 15,9 M
Net income 2024 0,10 M 0,12 M 0,12 M
Net cash position 2024 6,30 M 7,72 M 7,72 M
P/E ratio 2024 -
Yield 2024 -
Capitalization 8,08 M 9,90 M 9,90 M
EV / Sales 2023 0,19x
EV / Sales 2024 0,14x
Nbr of Employees 85
Free-Float 48,0%
More Financials
Company
Omega Diagnostics Group PLC is a United Kingdom-based medical diagnostics company. The principal activities of the Company and its subsidiaries are the manufacture, development and distribution of medical diagnostics products. The Company operates through two segments: Health and Nutrition and Global Health. The Health and Nutrition segment specializes in the research, development and production of kits to aid the... 
More about the company
Ratings of Omega Diagnostics Group PLC
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about OMEGA DIAGNOSTICS GROUP PLC
11/25IN BRIEF: Omega Diagnostics receives CD4 deferred consideration
AN
11/25Omega Diagnostics Receives $5 Million Deferred Consideration From CD4 Sale
MT
11/24Transcript : Omega Diagnostics Group PLC, Q2 2023 Earnings Call, Nov 24, 2022
CI
11/24Omega Diagnostics turns to interim loss but bets on US market
AN
11/24Earnings Flash (ODX.L) OMEGA DIAGNOSTICS GROUP Posts Fiscal H1 Revenue GBP3.4M
MT
11/24Earnings Flash (ODX.L) OMEGA DIAGNOSTICS GROUP Posts Fiscal H1 Loss GBX-0.90
MT
11/24Omega Diagnostics Group PLC Reports Earnings Results for the Half Year Ended September ..
CI
11/23UK earnings, trading statements calendar - next 7 days
AN
11/22UK earnings, trading statements calendar - next 7 days
AN
11/21UK earnings, trading statements calendar - next 7 days
AN
11/18UK earnings, trading statements calendar - next 7 days
AN
11/17UK earnings, trading statements calendar - next 7 days
AN
11/14Omega Diagnostics signs partnership deal for DNA reporting
AN
11/14Omega Diagnostics Group PLC Signs Partnership Agreement with Software Provider
CI
10/26TRADING UPDATES: Novacyt wins UK approval; React outlook confident
AN
More news
News in other languages on OMEGA DIAGNOSTICS GROUP PLC
11/25Omega Diagnostics reçoit une contrepartie différée de 5 millions de dollars de la vente..
11/24Earnings Flash (ODX.L) OMEGA DIAGNOSTICS GROUP affiche un chiffre d'affaires de 3,4 mil..
11/24Omega Diagnostics Group PLC annonce les résultats de ses bénéfices pour le semestre clo..
11/14Omega Diagnostics Group PLC signe un accord de partenariat avec un fournisseur de logic..
10/05Omega gagne 21% alors que le test rapide pour les maladies infectieuses montre une haut..
More news
Chart OMEGA DIAGNOSTICS GROUP PLC
Duration : Period :
Omega Diagnostics Group PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMEGA DIAGNOSTICS GROUP PLC
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 3,40 GBX
Average target price 12,00 GBX
Spread / Average Target 253%
EPS Revisions
Managers and Directors
Jag Grewal Chief Executive Officer & Executive Director
Christopher Paul Lea Chief Financial Officer & Secretary
Simon Gordon Douglas Independent Non-Executive Chairman
Jeremy Howard Millard Independent Non-Executive Director
Sector and Competitors